<p id="P1">Naive CD4
<sup>+</sup> T cells can be converted to Foxp3
<sup>+</sup> T regulatory cells (Tregs) in the periphery (iTregs), where induction
of
<i>Foxp3</i> gene expression is central to Treg differentiation. OX40 signaling is
known to inhibit
<i>Foxp3</i> expression and Treg induction, but the underlying mechanisms remain poorly
defined.
Here, we found that OX40 costimulation activates two distinct molecular pathways to
suppress
<i>Foxp3</i> expression in freshly activated naive CD4
<sup>+</sup> T cells. Specifically, OX40 upregulates BATF3 and BATF, which produce
a closed chromatin
configuration to repress Foxp3 expression in a Sirt1/7-dependent manner. Moreover,
OX40 can also activate the AKT-mTOR pathway, especially in the absence of BATF3 and
BATF, to inhibit Foxp3 induction, and this is mediated by phos-phorylation and nuclear
exclusion of the transcription factor Foxo1. Taken together, our results provide key
mechanistic insights into how OX40 inhibits Foxp3 expression and Treg induction in
the periphery.
</p><p id="P2">
<div class="figure-container so-text-align-c">
<img alt="" class="figure" src="/document_file/e1ac265e-671c-4d0b-bf18-f3d594e83f83/PubMedCentral/image/nihms-1502984-f0001.jpg"/>
</div>
</p><p id="P3">Zhang et al. show that OX40 inhibits Foxp3 expression by upregulating
BATF and BATF3
expression in activating CD4
<sup>+</sup> T cells, and BATF proteins close the Foxp3 locus by recruiting the histone
deacetylases
Sirt1/7. Additionally, OX40 activates the AKT-mTOR pathway to inhibit Foxp3 expression
in the absence of the BATF proteins.
</p>